MURFREESBORO, TN / ACCESSWIRE / January 22, 2021 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the fourth quarter ended December 31, 2020. NHI plans to issue its earnings release after the market closes on Monday, February 22, 2021, and will host a conference call on the following day, Tuesday, February 23, 2021, at 12:00 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 222-6529, with the confirmation number 21989300.
The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/39448 on Tuesday, February 23, 2021, at 12:00 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.
Contact: Dana Hambly
Director, Investor Relations
Phone: (615) 890-9100
SOURCE: National Health Investors, Inc.
View source version on accesswire.com:
https://www.accesswire.com/625450/NHI-Announces-Fourth-Quarter-2020-Earnings-Release-and-Conference-Call-Date
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…
MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…